Skip to content

A study to assess the added benefit of Ashtapad Rajat Shalaka Agnikarma in relieving low back pain in patients with lumbar spondylosis

Randomised controlled clinical trial to evaluate the add on effect of asthapad rajat shalaka agnikarma in management of katigat vata w.s.r. to lumbar spondylosis. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102575
Enrollment
70
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M471- Other spondylosis with myelopathy

Interventions

None listed

Sponsors

Dr Sandeep Rajendra Girase
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical features of Katigata Vata / lumbar spondylosis confirmed by Xray Patients of either sex between 30 to 60 years. Willing & able to participate and complete the study. Selection will be irrespective of gender, religion and other socioeconomic status

Exclusion criteria

Exclusion criteria: History of spinal surgery, fractures, malignancy, or systemic illness Pregnant and lactating women Tuberculosis of spine Contraindications for Agnikarma (skin disorders, bleeding disorders, uncontrolled diabetes, etc.)

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Ashtapad Rajat Shalaka Agnikarma in reducing pain, stiffness, and improving functional status in Katigata Vata with special reference to lumbar spondylosis.Timepoint: 10 days study with follow up on 7th & 10th day

Secondary

MeasureTime frame
Improvement in stiffness of the lower back. Improvement in range of movements of the lumbar spine. Reduction in tenderness over the lumbosacral region. Improvement in functional ability & daily activities. Reduction in associated symptoms such as radiating pain. Decrease in requirement of analgesic medications. Improvement in quality of life score.Timepoint: 10 days study with follow up on 7th & 10th day.

Countries

India

Contacts

Public ContactDr Sandeep Rajendra Girase

MES AYURVED MAHAVIDYALAYA

dryogeshborase@gmail.com8329008455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026